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Abstract 
The published Commentary by Hoppe et al. (Environ Sci Eur 27–28, 2015) makes a number of strong criticisms of 
Pilling et al. (PLoS One 8:e77193, 2013), which this authors’ response will show are either wrong, inaccurate or mislead-
ing. A selection of these misrepresentations include a claim that technical thiamethoxam was used rather than the 
commercial product. This is not true. Pilling et al. (PLoS One 8:e77193, 2013) clearly state that formulated commercial 
products were used which also included fungicides. It is claimed that there was a failure to quantify colony losses in 
winter. Again this is not true. These data were readily extractable from the original paper. It is claimed that 70 % of the 
colonies did not survive. For a multiple year study this is very misleading. The annual colony loss rate was 14.8 % for 
treated colonies and 16 % for control colonies, well within background colony loss rates reported by the EC Epilobee 
EU monitoring programme. Concerns are also raised regarding the PLOS One reviewing process. The reality is that 
Pilling et al. (PLoS One 8:e77193, 2013) was extensively reviewed by five referees during the original review process, 
followed by a second post-publication editorial review. These inaccurate and misleading statements are then used 
to infer that the data, methodology and conclusions of low risk to honeybees from Pilling et al. (PLoS One 8:e77193, 
2013) are untruthful and misleading. This inference is both absolutely untrue and inappropriate. Pilling et al.’s (PLoS 
One 8:e77193, 2013) paper is a summary of one the most comprehensive set of field studies ever conducted on 
honeybees, a fact recognised within both the second review by PLOS One and within the published EFSA Evaluation 
of Thiamethoxam.
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Background
In response to the increasing call for industry to be more 
transparent, Syngenta took the decision to publish the 
pivotal honeybee field studies that supported the honey 
bee safety of thiamethoxam. These field studies included 
12 separate pollen and nectar field residue trials and 
five long-term (4 consecutive years) field effects studies 
on honeybees carried out in four geographically wide-
spread locations in France. The primary purpose of these 
field trials was to investigate and test the bee safety of 
thiamethoxam. As such these studies have to be carefully 
designed to avoid as far as is possible any other potential 
confounding factors, e.g. exposure to other insecticides. 
In response to the criticism of Hoppe et  al. (2105) that 
the “design and adherence to the protocol was described 
inadequately” and that it was “doubtful whether the study 
was implemented in a traceable way”, it should be noted 
that these studies also have to comply with the strict, 
legally enforceable, quality control requirements of Good 
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Laboratory Practice (OECD [1]) and comply with rel-
evant international guidelines, e.g. in this case EPPO 170, 
2010 [2]. One of the challenges faced during the drafting 
of the publication of these field trials was how to sum-
marise in a concise publication manuscript the extensive 
methodology information from effectively 13 separate 
field trials as well as the vast amount of data that were 
generated. Initially two separate papers were drafted 
to summarise the data on residues in pollen and nectar 
and the other on effects on honeybee colonies. However, 
PLOS One insisted that they be combined into a single 
manuscript. In the end, the final Pilling et al.’s [3] paper 
was 13 pages long with a substantial supplementary 
information section. Whilst many of the criticisms made 
by Hoppe et al. [4] can be addressed by a more thorough 
reading of the original Pilling et al.’s [3] paper, the other 
criticisms, particularly of the methodology used, are fully 
addressed in the original study reports for these field 
studies which were submitted to EFSA and other Regu-
latory Authorities. One of the comments made by this 
EFSA evaluation (EFSA 2013, [5]) of these field stud-
ies was “The study was well performed and was to GLP. 
The study was very comprehensive and was scientifically 
sound.” (See comment on Hecht-Rost 2009 study on page 
39 of Doc 3067prr in EFSA link http://registerofques-
tions.efsa.europa.eu/roqFrontend/outputLoader?output
=ON-3067). A detailed authors’ response to each of the 
points raised by Hoppe et al. [4] is listed below:
Detailed comments on Hoppe et al. [4]
EC neonicotinoid restriction in use
Hoppe et al. [4] quotes “a 2 yr Moratorium implemented 
by the European Commission”. This again is incorrect. 
The restriction on neonicotinoids implemented by Euro-
pean Commission is not time bound to 2 years.
Usage of non‑commercial product for experiments
In [4], Hoppe et al. claim that “the active ingredient only 
was used for seed dressing and not a commercial prod-
uct”. This statement is wrong. Pilling et  al.’s [3] paper 
clearly states that formulated products “as per normal 
seed treatment practice” were used, which did for exam-
ple include the use of the fungicides, metalaxyl-M and 
fludioxonil. Therefore, all the text that follows under this 
point is not relevant and based on a wrong assumption.
Hoppe et al. [4] point out that Pilling et al.’s [3] study is 
carried out at a lower application rate than the maximum 
recommended application rate
Pilling et al.’s [3] study was designed to only address the 
pre-dominant commercial rates that were most com-
monly used in Europe for these crops. The higher hectare 
rates registered in few EU countries at the time of the 
EFSA review, which exceeded the rates tested in the stud-
ies described in Pilling et al. (2013), were predominantly 
the result of outdated old seeding rates and not in line 
with current realistic seeding rates in Europe. Another 
important point that is missed by Hoppe et al. [4] is that 
the most important and relevant application rate for a 
risk assessment, investigating the effect of systemic resi-
dues of thiamethoxam in pollen and nectar from a seed 
treatment application, is actually the seed loading rate 
(i.e. g active ingredient/seed) not the amount of active 
ingredient applied per hectare, i.e. it is the seed loading 
that will drive the systemic residue concentration of the 
active ingredient in the pollen and nectar not the applica-
tion rate per hectare.
Separation distance of 2 km between treatment 
and control
Whilst Pilling et al. [3] do quote “about 2 km” as the sepa-
ration difference, this was the minimum target and in the 
reality of the trials, this was often exceeded.
No evidence to support the isolation of trials from other 
bee attractive crops
Whilst no detailed location information is presented in 
Pilling et  al. [3], the latitude and longitude coordinates 
are available for all the test and control sites within the 
full study reports submitted to EFSA. Field surveys were 
also carried out at farm level each year prior to trial com-
mencing to confirm that the sites were isolated from bee 
attractive crops for the duration of the exposure phase.
Time window of exposure
Hoppe et  al. [4] criticise the time window of exposure 
being too short and “not field relevant”. The fact is that 
this study was specifically investigating the risk from sys-
temic residues in pollen and nectar from thiamethoxam-
treated crops in flower. So the time window of exposure 
in Pilling et al. [3] was for the complete flowering period 
of the crop for each of the plots being monitored. The 
duration of the flowering was dependent on local envi-
ronmental conditions. One would question how a com-
plete flowering period of a commercially planted crop 
cannot be field relevant to investigating risk from sys-
temic residues in pollen and nectar?
Use of woodland sites
Hoppe et al. [4] state that keeping the colonies in wood-
land sites “without intensive agricultural crops” does not 
reflect normal beekeeping practice. However, for the pur-
pose of investigating whether systemic residues in pol-
len and nectar from flowering crops seed treated with 
thiamethoxam present any risk to honeybee colonies, it 
is absolutely necessary to isolate the experiment from any 
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other confounding pesticide inputs during the post flow-
ering period. For this reason, the post flowering sites had 
to be located away from other agricultural fields. In fact, 
if the colonies had been located close to other bee attrac-
tive agricultural crops (as may occur in beekeeping) the 
results could be challenged based on dilution of residues. 
Latitude and longitude coordinates of the over-wintering 
sites were not included in Pilling et al. [3] for reasons of 
brevity but are available in raw data. Field surveys were 
also carried out prior to selection of over-wintering sites.
Pesticide contamination history of sites
Hoppe et al. [4] state that pesticide contamination history 
of site was not assessed. Whilst the pesticide contamina-
tion history information for each site was not stated in 
Pilling et al. [3] (for brevity), it was assessed for 3 years 
prior to the start of the experiment and was included in 
the full study reports submitted to EFSA.
Residue analysis
Residue analysis was only carried out for thiamethoxam 
and its metabolite since these were the test items being 
studied and every effort was made to prevent exposure 
of colonies to any other pesticides during the exposure 
period, e.g. through implementation of isolation dis-
tances and over-wintering sites. Other pesticides were 
applied as necessary outside the flowering period (and 
hence outside the exposure period of trial) to ensure a 
viable crop.
Cumulative colony mortality
This quoted figure of 70  % total colonies lost in Hoppe 
et al. [4] is completely misleading. This was a 4-year trial 
so the most appropriate way of looking at the colony loss 
data is to express the number of colonies lost per year. 
Since this is how EC Honeybee Colony Loss Monitoring 
surveys, such as EPILOBEE (Laurent et  al. [6]), express 
the national colony loss statistics for Europe. The data 
from Pilling et  al. [3] indicate an annual colony loss of 
14.8  % per year for treated colonies and 16  % for con-
trol colonies. This is well within the normal range expe-
rienced by European Beekeepers and the numbers of 
colonies lost were similar across treatment and controls. 
The “male brood only” effects that are discussed and 
attributed to thiamethoxam in Hoppe et al. [4] occurred 
equally in control and treatment colonies.
Colony loss data in the winter
Hoppe et al. [4] state that “no data were reported for col-
ony losses during the winter”. They also go on to present 
different colony loss numbers from Pilling et al. [3] based 
on their analysis of “raw data” although we are unclear 
where these data originated. Although Pilling et  al. [3] 
did not separate out over-wintering colony loss data, it is 
easily calculated from Table 2 within the original paper. 
However, for clarity we have separated out over-winter-
ing and total colony loss data below in Table 1.
As can be seen from Table 1, the control and treatment 
colonies showed a similar pattern of both total and over-
wintering colony losses. Also, the male brood only effects 
referenced by Hoppe et  al. (2015) are equally present 
in both control and treated colonies. So once again the 
inference that we are hiding or misrepresenting data that 
show a treatment-related effect of thiamethoxam is fun-
damentally incorrect.
Rundlof et al.’s [7] study
Hoppe et al. [4] compare the methodology of Pilling et al. 
(2013) with the more recent Rundlof et al.’s [7] study, sug-
gesting the former study has more deficiencies. However, 
what they fail to point out is that the honeybee results 
for these two sets of field studies were the same, i.e. there 
were no detectable effects of the neonicotinoid seed 
treatment on honeybee colonies.
Lack of statistical analysis
Hoppe et  al. [4] criticise Pilling et  al. [3] for a lack 
of statistical analysis. The difficulty of including 
Table 1 Total colony losses and  over-wintering colony 
losses represented from  Table  2 in  Pilling et  al. (2013) 
[includes colonies lost to  AFB (1 from  the control group 
and 3 from the treated group at a single site in 2007)] [2]
Control Treated
Total Over‑winter Total Over‑winter
Maize, n = 18
 2006 0 0 1 0
 2007 1 0 8 2
 2008 3 0 7 1
 2009 7 1 1 1
 2010 6 6 4 4
 Total 17 7 21 8
 Average per year 4.25 1.4 4.2 1.6
 Average % colonies 23.6 7.8 23.3 8.9
Oilseed rape, n = 12
 2005 1 0 0 0
 2006 0 0 0 0
 2007 0 0 3 3
 2008 2 2 0 0
 2009 1 1 0 0
 Total 4 3 3 3
 Average per year 1 0.75 0.75 0.75
 Average % colonies 8.33 6.25 6.25 6.25
 Overall % 16.0 7.0 14.8 7.6
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sufficient statistical replication in the design of 
large-scale honey bee field trials, such as this, is well 
described in the both the original Pilling et  al.’s [3] 
paper and in the EPPO [2] Field testing Guideline fol-
lowed. Both clearly state that although replication is 
desirable it is not practically feasible because of the 
isolation requirements of the study design. This aspect 
is discussed very clearly in Pilling et  al. [3] and was 
accepted by the Journal.
Inadequate refereeing process
Hoppe et  al. [4] question PLOS One’s decision to pub-
lish Pilling et  al.’s [3] paper, based on the above list 
of criticisms (most of which we have now shown are 
either incorrect or unjustified). However, it should 
be noted that Pilling et  al.’s [3] paper was thoroughly 
peer reviewed by an academic editor and five different 
reviewers prior to publication. Furthermore, follow-
ing comments received by the Journal after publication, 
PLOS One carried out a second additional review of this 
paper, by a member of the PLOS One editorial board. 
Once again this paper was accepted as stands (see link to 
detailed comments from this second review http://www.
plosone.org/annotation/listThread.action?root=82356). 
One of the comments made by the editor during this 
second review was “The effort was comprehensive and 
seems honestly described.”
Conclusions
We contend that the alleged deficiencies claimed by 
Hoppe et al. [4] to undermine the conclusions of Pilling 
et al. [3] are incorrect, unjustified or are clear misunder-
standings of the design, conduct and purpose of the orig-
inal regulatory field studies, which could have been easily 
addressed by clarification with the authors.
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